FDA approves Genentech’s Xolair for food allergies (OTCMKTS:RHHBY)
Bet_Noire The FDA has approved Roche's (OTCQX:RHHBY) asthma drug Xolair, which was developed by Roche unit Genentech, for the additional ...
Bet_Noire The FDA has approved Roche's (OTCQX:RHHBY) asthma drug Xolair, which was developed by Roche unit Genentech, for the additional ...
The much-awaited monsoon season has finally arrived, marking a respite from the overbearing summer heat. Despite the common belief that ...
Peanut allergy is one of the most common and dangerous food allergies. WASHINGTON — An experimental skin patch is showing ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.